Barrington Research Reiterates Buy Rating on Concentrix Corporation

Barrington Research maintains its buy rating for Concentrix Corporation with a target price of $38, a 56.77% upside from the current price.

Editorial illustration for Concentrix Corporation (CNXC)

Key Points

  • Barrington Research reaffirmed its buy rating on Concentrix Corporation (CNXC) with a target price of $38.
  • Barrington Research's $38 price target implies 56.77% upside from Concentrix Corporation's ($CNXC) current $24.24 share price.
  • Concentrix shares traded at $25.08 on Tuesday with a market cap of about $1.46 billion.
  • Major institutional holders like AQR Capital Management increased their stakes significantly in Concentrix.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Barrington Research has reaffirmed its buy rating on Concentrix Corporation (NasdaqGS: CNXC), setting a target price of $38. The decision was made by analyst Vincent Colicchio and announced on June 22, 2026. Shares of Concentrix traded at $25.08 on Tuesday.

Other Institutional Activity in Concentrix

Several institutional investors have been active in Concentrix recently. AQR Capital Management LLC significantly increased its holdings by 1,881,581 shares, now holding 4,831,868 shares valued at approximately $132.2 million, marking a 63.8% increase. FMR LLC also boosted its position by 1,414,243 shares, reaching a total of 4,223,282 shares worth about $115.5 million, reflecting a 50.3% increase. BlackRock, Inc. added 235,325 shares, ending with 4,062,197 shares valued at roughly $111.1 million, a 6.1% increase. Dimensional Fund Advisors LP and Pzena Investment Management LLC also increased their stakes, with Dimensional adding 460,108 shares and Pzena adding 16,016 shares.

Concentrix Corporation Stock Down 17.5%

As of Tuesday, Concentrix Corporation's shares were trading at $25.08. The company, which operates in the technology sector providing information technology services, has a market capitalization of approximately $1.46 billion. It has a forward P/E ratio of 1.86 and a beta of 0.423, indicating lower volatility compared to the market. The stock's 52-week range is between $22.05 and $62.14, with a 50-day moving average of $26.25 and a 200-day moving average of $36.38.

12-month forecast

$CNXC price target

Past daily closes and this analyst's 12-month price target. Not investment advice.

Insider Buying and Selling at Concentrix Corporation

Recent insider transactions at Concentrix Corporation include several buys. On April 9, 2026, Valentine Andre, the Chief Financial Officer, purchased 2,500 shares at an average price of $27.95. Earlier, on March 26, 2026, Christopher Caldwell, the President and CEO, bought 1,000 shares at $26.97. Additionally, multiple insiders, including Laverne Council, Jennifer Deason, and Kathryn Hayley, each acquired 7,701 shares on March 25, 2026.

Analysts Set New Price Targets

On June 22, 2026, Barrington Research maintained its buy rating for Concentrix with a target price of $38. Other analysts have also shown confidence in the stock. Canaccord Genuity maintained a buy rating with a higher target of $55 on March 25, 2026, while Baird set a target of $40 with a buy rating on the same day. The consensus among analysts includes a mean target price of $41.25, with four analysts providing opinions.

About Concentrix Corporation

Concentrix Corporation, based in Newark, California, specializes in designing and running customer experience solutions worldwide. The company caters to various industries, including technology, retail, and healthcare, offering services like customer lifecycle management, analytics, and digital transformation. Led by CEO Christopher A. Caldwell, Concentrix employs around 455,000 people globally.

Bottom Line

Barrington Research's reaffirmation of its buy rating for Concentrix Corporation indicates continued confidence in the company's potential. Investors closely watch these ratings as they reflect analysts' insights into the company's prospects. Remember, these ratings are based on past performance and market conditions as of the filing date, and actual future performance may vary.

Get Concentrix Corporation alerts

New 13F filings, insider trades, and analyst moves on $CNXC, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.